THANKTIVA Trademark

Trademark Overview


On Friday, April 7, 2023, a trademark application was filed for THANKTIVA with the United States Patent and Trademark Office. The USPTO has given the THANKTIVA trademark a serial number of 97877313. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, January 21, 2025. This trademark is owned by ImmunityBio, Inc.. The THANKTIVA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services; medical information; providing a website featuring medical information in the fields of pharmaceuticals, immunotherapy, immuno-oncology, cancer, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases

Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases
thanktiva

General Information


Serial Number97877313
Word MarkTHANKTIVA
Filing DateFriday, April 7, 2023
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, January 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements


Goods and ServicesMedical services; medical information; providing a website featuring medical information in the fields of pharmaceuticals, immunotherapy, immuno-oncology, cancer, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases
Goods and ServicesMedical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 2, 2023
Primary Code042
First Use Anywhere DateTuesday, April 23, 2024
First Use In Commerce DateTuesday, April 23, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 2, 2023
Primary Code044
First Use Anywhere DateTuesday, April 23, 2024
First Use In Commerce DateTuesday, April 23, 2024

Trademark Owner History


Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, April 11, 2023NEW APPLICATION ENTERED
Tuesday, May 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 1, 2023ASSIGNED TO EXAMINER
Tuesday, November 7, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 7, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, November 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 7, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, November 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 17, 2024USE AMENDMENT FILED
Wednesday, July 17, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, July 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 17, 2024SOU EXTENSION 1 FILED
Thursday, September 19, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 19, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 1, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, January 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 22, 2025ASSIGNED TO LIE